AMR Centre

Growth Investment

Based at Alderley Park, the Anti-Microbial Research Centre aims to accelerate the development of new antibiotics by providing development services to companies around the world in return for a commercial share from new products developed.

Anti-microbial resistance is now recognised as a threat to humanity and the AMRC is a key part of the UK’s response to this global threat. AMRC is a founder partner of CARB-X, a US-based anti-microbial grant funder which is investing $455m into suitable projects around the world. The costs of AMRC’s unique development capabilities are significantly reduced thanks to CARB-X grants, while the scientific risks are reduced through access to the CARB-X panel of world leading experts.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Nick Wright


view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300